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Diabetic ketoacidosis (DKA) occurs in 20–40% of children with newly diagnosed type 1 diabetes mellitus [1] and may later recur in association with 
illness or noncompliance with treatment. Clinically apparent 
cerebral edema occurs in approximately 1% of episodes of DKA 
in children and is associated with a mortality rate of 40–90% [2]. 
Cerebral edema is responsible for 50–60% of diabetes-related 
deaths in children [2,3]. Other causes of neurological deterioration 
in DKA include hypoglycemia, central nervous system (CNS) 
infections, and CNS hemorrhage or thrombosis, and electrolyte 
disturbances [4]. Even though the clinical features, management, 
and outcome of DKA are well described, there is a paucity of 
data, especially from South India. This is especially true with 
respect to cerebral edema associated with DKA. Early recognition 
of its presence and identification of risk factors for cerebral 
edema before the initiation of treatment and during treatment 
are of utmost importance for preventing morbidity and mortality. 
Hence, we undertook the study in a tertiary care teaching hospital 
in South India.
MATERIALS AND METHODS
This retrospective case review was conducted in the pediatric 
intensive care unit (PICU) of a tertiary care teaching hospital 
during the period from August 2012 to November 2017. The 
study subjects included all patients with biochemically confirmed 
DKA [4] admitted to the PICU (Table 1). They were further 
classified based on the severity of acidosis [5] (Table 1). Patients 
having other comorbidities such as chronic kidney disease and 
other causes of high anion gap metabolic acidosis were excluded.
From the patient records hourly monitoring of clinical features 
(heart rate, respiratory rate, blood pressure, urine output, oxygen 
saturation, sensorium, and presence of headache and vomiting) 
were recorded. Details of hourly blood sugar and 4–6 hourly 
venous blood gas and serum electrolytes were noted. Blood urea 
nitrogen (BUN) and creatinine values at admission also recorded.
Hypernatremia and hyponatremia were defined as measured 
serum sodium level >150 mmol/L and <135 mmol/L, respectively. 
Hyperkalemia and hypokalemia were defined as serum potassium 
level >5.5 mmol/L and <3.5 mmol/L, respectively. A case of cerebral 
ABSTRACT
Objective: To study the clinical profile of children admitted with diabetic ketoacidosis (DKA) in the pediatric intensive care 
unit (PICU) of a tertiary care teaching hospital. To assess the risk factors for the development of cerebral edema in children 
with DKA. Methods: This retrospective case review was conducted in the PICU of a tertiary care teaching hospital. Details 
of children admitted with DKA during the period from August 2012 to November 2017 were collected with respect to clinical 
features, lab parameters, management, and outcome. The characteristics of children with and without cerebral edema were 
compared. The data were then analyzed statistically using SPSS software. Results: Among the 51 cases analyzed 66.7% were 
females and 35.3% were newly detected cases. 51.5% of the previously diagnosed and 50% of the newly detected subjects 
had an infection as the precipitating event. Vomiting was the most common clinical presentation (64.7%). Mean time taken for 
acidosis correction was 22.65 h. 12 patients (23.53%) developed cerebral edema during the course of treatment. Neurologic 
deterioration developed at a median of 6 h (range 1.5–36 h) after the initiation of treatment. An increased incidence of cerebral 
edema was found in patients who received excess fluid boluses before starting insulin treatment (p=0.02) and newly detected 
cases (p=0.037). In those who developed cerebral edema the mean blood sugar value at admission was found to be significantly 
higher (p=0.013). No deaths or neurological sequelae were reported. Conclusions: Infections are an important precipitating 
factor for DKA. A significant proportion of children developed cerebral edema during treatment. New cases, excess intravenous 
fluid boluses, high mean blood sugar at admission, and bicarbonate administration were identified as risk factors for cerebral 
edema.
Key words: Diabetic ketoacidosis, Cerebral edema, Children, Southern Kerala
Krishnan et al. Diabetic ketoacidosis and related cerebral edema among children
Vol 5 | Issue 2 | Feb 2018 Indian J Child Health 74
edema was suspected when deterioration in the level of consciousness 
with GCS fall more than 2 was accompanied by one or more signs 
of raised intracranial pressure (hypertension, bradycardia, breathing 
pattern abnormalities, pupillary abnormalities, squint, blurred disc 
margins, decerebrate, or decorticate posturing). The absence of focal 
neurological deficits and improvement with antiedema measures 
were taken as a confirmation to the diagnosis of cerebral edema 
and to exclude other causes such as cerebral venous thrombosis 
and hemorrhage. Other causes of neurological deterioration 
such as hypoglycemia, intracranial infections, and metabolic 
encephalopathy were ruled out clinically and biochemically.
The treatment protocol followed was as per the standard 
guidelines [1,6] (Table 2).
Resolution of ketoacidosis is considered as the end of treatment 
of DKA. Potassium replacement was given as required as per 
guidelines. Antibiotics were administered whenever bacterial 
infection was suspected and continued in confirmed cases.
Corrected sodium and serum osmolality at admission were 
calculated and used for analysis [1] (Table 3).
All treatment details including details of fluids received before 
admission were collected. Complications which developed before 
and during treatment were collected with special reference to the 
development of cerebral edema. Time taken for correction of 
ketoacidosis and time interval between the initiation of treatment 
and diagnosis of cerebral edema noted from case records. The 
characteristics of children with and without cerebral edema were 
also compared in relation to fluids administered, blood sugar and 
serum osmolality at admission, blood gas, and electrolyte values 
to determine the risk factors for cerebral edema.
Data were statistically analyzed using SPSS version 16. 
Descriptive statistics were reported at baseline, with continuous 
data expressed as a mean±standard deviation and categorical 
data expressed as counts. Children with and without cerebral 
edema were compared. All continuous explanatory variables 
were presented as means, with differences between the 2 
groups compared by means of independent t-tests. Categorical 
explanatory variables were summarized as frequencies 
and percentages, with differences between the 2 groups 
analyzed using the Chi-square test and Fisher exact test when 
appropriate. p<0.05 was considered statistically significant. 
Permission was obtained from the Ethical Committee before 
conducting the study.
RESULTS
A total of 51 cases satisfying the criteria for DKA were analyzed. 
Of these 17 were males (33.3%) and 34 were females (66.7%). 
Male to female ratio was 1:2. Mean age was 9.16±3.79 years 
(range 1–15 years). A maximum number of cases were identified 
in the age group of >10 years (49%) (Table 4).
There were 18 newly detected cases (35.3%) and 33 known 
diabetic cases (64.7%). 3 patients had comorbidities, 2 had 
hypothyroidism, and 1 had congenital cytomegalovirus infection. 
Positive family history could be elicited in 10 patients (19.6%). 
Parents were affected in 2 cases and grandparents in the rest. All 
of them had type 2 diabetes mellitus.
Evidence of infection was noted among 26 (49%) children 
(Fever alone-9, acute lower respiratory infection-7, culture 
positive urinary tract infection-4, acute diarrheal disease-2, 
abscess-2, and sepsis-2). One case with sepsis had acinetobacter 
grown in blood culture. 51.5% of the known diabetics and 50% 
of the newly detected ones had an infection (Table 4). All the 
7 patients with respiratory infection had clinical evidence of 
pneumonia characterized by localized crepitations and 4 also had 
radiological evidence of pneumonia. One patient had an abscess 
of thigh, and another had abscess of abdominal wall both of them 
did not have fever. 9 patients had high spiking fever without 
definite focus out of which 7 were CRP positive and the other 2 
had persistent fever even after resolution of DKA.
Among the 51 cases, 4 had mild DKA (7.8%), 14 had moderate 
(27.5%), and 33(64.7%) had severe DKA. A significant proportion 
Table 1: Definition and classification of DKA
Biochemical criteria Classification based on severity
Severity Venous pH Bicarbonate
(mmol/L)
Blood glucose>200 mg/dL Mild <7.3 <15
Venous pH<7.3 or 
bicarbonate<15 mmol/L
Moderate <7.2 <10
Ketonuria Severe <7.1 <5
DKA: Diabetic ketoacidosis
Table 2: DKA treatment protocol
Time Therapy
1st h Normal saline bolus 10 ml/kg in severely volume depleted
10–20 ml/kg in shock
2nd h until DKA resolution {Fluid deficit+(maintenance 2×)−bolus}/47
Insulin infusion-0.1 U/kg/h
Fluid deficit-
Mild 50 ml/kg
Moderate to severe 85–100 ml/kg
Ketoacidosis resolution (blood pH>7.3, plasma bicarbonate>15 mmol/L) Regular insulin at 1 U/kg/day (in 3–4 divided doses) given 
subcutaneously.
Oral feeds started 30 min later.
Insulin infusion stopped after 1 hour of subcutaneous insulin
DKA: Diabetic ketoacidosis
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of children>10 years had severe DKA compared to <10 years 
(p=0.039). Vomiting was the most common clinical presentation 
(64.7%) (Table 4). Dehydration assessed before starting fluid 
correction was 5% for 1 patient, 8.5% for 47 patients, and 10% 
for 3 patients. For one patient, the percentage of dehydration was 
later increased to 11% due to worsening of acidosis in between. 
Shock was diagnosed at admission in 9 patients (17.6%) of which 
6 patients were given inotropic support also. 12 children (23.5%) 
received intravenous fluid boluses before hospitalization in our 
institution, and 14 (27.5%) had received bolus dose of insulin 
too before admission. Fluid received before admission was not 
subtracted during the calculation of fluid therapy. 28 patients 
(55%) received 10 ml/kg of fluid bolus, 14 (27.4%) 10–20 ml/kg, 
and 8 patients (15.6%) received >20 ml/kg from our hospital 
before starting insulin infusion. All the patients who received 
>20 ml/kg fluid had severe DKA, and 6 children needed inotropes 
also. 2 had septic shock, and the rest 4 children were weaned off 
inotropes in <6 h. Prolonged acidosis causing transient cardiac 
dysfunction may be the cause for a fluid refractory shock in them.
The biochemical parameters at admission and after 6 h are 
given in Table 5.
The mean blood sugar at admission was 462.06±88.08 mg/dL. 
BUN was abnormal (>20) in 16 cases (31.4%). Mean BUN was 
19.85±13.93 mg/dL. Measured serum creatinine was abnormal 
in 27 (52.9%). The mean calculated serum osmolality was 
300.84±11.44 mOsm/kg).
At admission 46 patients (90.2%) had normal sodium, 4 (7.8%) 
had hyponatremia, and only 2 (3.9%) had hypernatremia. Maximum 
sodium level during treatment was also analyzed. 42 (82.3%) 
patients had normal sodium, 7 (13.7%) had hyponatremia, and 
only 2 (3.9%) had hypernatremia. A mean change in sodium level 
of 8.21±4.89 mmol/l (range 1–20) was noted during treatment.
At admission 82.4% had normal potassium (K) levels, 3.9% had 
hypokalemia, and 13.7% had hyperkalemia. Out of the 7 patients with 
hyperkalemia, only 2 had serum K level >6, but electrocardiogram 
changes were not present. Elevated keto acids can interfere with 
estimation of serum creatinine and give falsely high values. But 
both of our patients with serum potassium >6 had a deranged BUN 
and serum creatinine which normalized after correction of acidosis. 
During treatment 18 (35.3%) developed hypokalemia (Table 6).
Maximum dose of insulin used during treatment was 
0.15 U/kg/h for 4 patients. A minimum dose of 0.05 U/kg/h was 
needed in 5 patients. Concentration of dextrose had to be increased 
to 10% for 13 (25.5%) children and 12.5% for 6 children (11.8%) 
during the course of treatment to prevent blood glucose from 
falling <150 mg/dl while acidosis was persisting. 37 patients 
(72.5%) received fluids containing 0.9% saline only whereas 
14 (27.5%) received 0.45% saline containing fluids also during 
correction. 3 patients received bicarbonate during treatment in 
view of severe acidosis.
Meantime taken for ketoacidosis correction was 22.65 ± 14.25 h 
(range 6–96 h) (Fig. 1). The 2 patients who presented with sepsis 
Table 3: Corrected sodium and serum osmolality
Measured parameter Formula
Corrected Na Measured serum Na+([(glucose 
concentration-100)÷100]×1.6)
Serum osmolality (2×Na)+(glucose÷18)+(BUN÷2.8)
Glucose in mg/dl, serum Na in mmol/L, BUN in mg/dl and serum osmolality (mOsm/
kg). BUN: Blood urea nitrogen
Table 4: Baseline clinico‑epidemiological characteristics of 
patients with DKA at admission
Age in years n (%)
1–2 4 (7.8)
2–5 5 (9.8)
5–10 17 (33.3)
>10 25 (49)
Total 51 (100)
Cases Etiology of DKA
Known diabetic Missed dose 5 (9.8)
Infection 12 (23.5)
No identifiable cause 11 (21.6)
Infection with missed dose 5 (9.8)
Newly detected No identifiable cause 9 (17.6)
Infection 9 (17.6)
Total 51 (100)
Symptoms at admission
Polyuria and polydipsia 15 (29.4)
Abnormal sensorium 9 (17.6)
Abdominal pain 11 (21.6)
Vomiting 33 (64.7)
Lethargy 14 (27.5)
Respiratory distress 20 (39.2)
Fever 20 (39.2)
DKA: Diabetic ketoacidosis
Table 5: Biochemical parameters
Parameters Mean±SD
At admission 6 h after starting 
treatment
Venous pH 7.04±0.14 7.2±0.11
Bicarbonate (mmol/L) 5.38±2.71 9.20±3.95
Partial pressure of 
venous CO2 (mmHg)
16.36±5.24 22.64±6.25
SD: Standard deviation
Table 6: Serum electrolyte values of children with DKA
Parameters Mean±SD (mmol/l) Range
K at admission 4.67±0.72 3.0–6.4
Maximum K during 
treatment
4.5±0.67 3.0–6.1
Minimum K during 
treatment
3.63±0.63 2.2–4.9
Measured Na at 
admission 
134.04±5.16 120–151
Corrected Na at 
admission
139.85±5.14 125.9–157.5
Maximum Na during 
treatment
140.29±5.28 132–153
DKA: Diabetic ketoacidosis, SD: Standard deviation
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needed more time for correction of acidosis (96 and 36 h, 
respectively). In fact, the patient who needed 96 h for acidosis 
correction had culture positive sepsis. These patients were 
continuing to have high anion gap metabolic acidosis ruling out 
hyperchloremia as a cause of prolonged acidosis.
One patient with sepsis and DKA needed ventilatory support. 
Indication for ventilation was refractory shock and severe acidosis 
(pH 6.89 and serum bicarbonate of 1.6). This child had evidence 
of cerebral edema 1.5 h after starting treatment. No deaths were 
reported during the study period. 12 patients (23.53%) among the 51 
children developed cerebral edema during the course of treatment. 
The diagnosis was based on the deterioration in mental status as 
evidenced by a fall in Glasgow Coma Scale by two or more in all the 
12 patients. This was associated with bradycardia and hypertension 
in 8 patients, decerebrate posturing in 2 patients, and bradycardia 
alone in 2 patients. None of the patients had focal neurological 
deficits. Neurologic deterioration developed a median of 6 h (range-
1.5–36 h) after the initiation of therapy for DKA (Fig. 2).
Nine patients were getting isotonic fluids during the event 
whereas 3 were getting half normal saline. 6 patients received 
mannitol as treatment, 5 received 3% saline, and 1 patient received 
both. None of them needed ventilation during the event, and all 
the patients recovered completely with antiedema measures and 
DKA management without any neurological sequelae. Other 
causes of neurological deterioration were excluded clinically and 
biochemically. Imaging was not done in any of our patients.
The baseline characteristics of the children with and without 
cerebral edema were compared.
The mean blood sugar value of the group with cerebral edema 
was found to be significantly higher compared to that of those 
without cerebral edema (Table 7) (Fig. 3).
An increased incidence of cerebral edema was noted in patients 
who received intravenous fluid boluses before starting treatment 
of DKA (p=0.02), newly detected cases (p=0.037) and those who 
received bicarbonate during treatment (p=0.016) (Table 8).
No difference was noted between the two groups with respect 
to the presence of infection, shock at presentation, and receiving 
insulin before starting treatment. The time taken for acidosis 
correction was also not different between the two groups. However, 
patients in the cerebral edema group showed more fluctuation in 
sodium level during treatment (p=0.091) (Table 9) (Fig. 4).
DISCUSSION
In this study, we analyzed 51 children diagnosed over a period of 
5years and 3 months. A definite female preponderance was noted 
(66.7%) with a male to female ratio of 1:2. In a study from the 
UK [7] females accounted for 60.5% cases whereas in a study from 
Srinagar, North India males were dominant (70%) [8]. In most 
of the studies mean age of affected children is around 7–9 years 
[8-10] and in our study, a mean age of 9.16years was noted.
One important observation made by us is that 50.9% of patients 
had an infection as a precipitating factor. Both known diabetic 
cases and newly detected cases had around equal proportion (51.5 
% and 50%, respectively). Coexistent infection can delay acidosis 
correction or can even worsen acidosis. In 2 cases of sepsis with 
Figure 1: Time taken for correction of acidosis in children with 
diabetic ketoacidosis
Figure 2: Time interval between the initiation of treatment and onset 
of cerebral edema in children with diabetic ketoacidosis
Figure 3: Mean blood sugar level at admission in children with 
diabetic ketoacidosis with cerebral edema and without cerebral 
edema
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DKA in our series, the time taken for acidosis correction was 
36 and 96 h against the mean value of 22.65 h. This highlights 
the importance of initial empirical antibiotics even if  overt 
infection is absent especially in developing countries like ours 
where infection risk is high. Antibiotics may be stopped as soon 
as bacterial infection is ruled out. Similar to our study, a much 
higher rate (44%) of infection including death due to septic shock 
was observed in a study from North India [10]. In a study from 
Egypt also evidence of infection was seen in 21.9% [11].
The most common clinical presentation in our study population 
was vomiting followed by respiratory distress and fever. This 
emphasizes the importance of checking blood sugar in any sick 
patient presenting with similar clinical picture and also highlights 
the importance of proper history elicitation. In literature usually 
younger age shows more proportion of severe cases [12-14] 
whereas in our series children of >10 years age group showed 
more of severe DKA. In our study, the majority of children in 
whom shock was detected had severe DKA (p=0.0193) which is 
similar to the study from Srinagar [8].
In population studies, the mortality rate from DKA in children 
is 0.15–0.30% [15-17]. In a large multicenter study of DKA from 
the UK [2] 61 children out of 6977 hospitalization for DKA had 
cerebral edema (0.9%).Of the 61 children 57% recovered, 21% 
survived with permanent neurologic dysfunction, and 21 % died. 
During the study period, two other children died due to cardiac 
arrest associated with hypokalemia and hypocalcaemia [2]. In 
this study neurologic deterioration developed at a median of 
7 h (range 0–25) after the initiation of therapy for DKA but in 
5 %, all of whom had radiographically apparent cerebral edema 
it occurred before the initiation of therapy. In studies from the 
US also 0.5–1.5% of cerebral edema has been reported which 
accounts for 90% of DKA related mortality [18]. In studies 
from North India 13.2% cerebral edema was noted with 13.2% 
mortality [10]. In another study from Delhi, 14.5% of patients 
developed cerebral edema [19].
In our study even though a much higher rate of cerebral 
edema was detected (23.53%) all patients survived without 
neurological sequelae. Early detection and management may be 
the cause for 100% survival without sequelae. As all the children 
recovered completely within hours of neurological deterioration, 
cerebral venous thrombosis and hemorrhage could be excluded 
with reasonable certainty, and hence, imaging was not done in 
any of our patients. Cerebral edema may occur in the absence of 
acute changes in computed tomograms [20]. Unless early clinical 
diagnosis is made delay can lead to mortality and sequelae.
Clinically significant cerebral edema usually develops within 
the first 12 h after treatment has started, but can occur before 
treatment has begun [2,21,22] or rarely may develop as late as 
24–48 h after starting treatment [1,2,23]. In our study, cerebral 
edema developed at a median of 6 h (range-1.5–36 h) after starting 
treatment. None had cerebral edema before starting treatment 
unlike others studies [2].
The cause of cerebral edema is controversial. Rapid fluid 
administration with abrupt changes in serum osmolality [24,25], 
hypotonic fluids, dehydration, and cerebral hypoperfusion with 
associated with DKA-related cerebral injury [2,26] all have been 
Figure 4: Mean change in sodium level in mmol/l during treatment in 
children with diabetic ketoacidosis with cerebral edema and without 
cerebral edema
Table 7: Demographic and initial lab data of children with DKA with and without cerebral edema
Variable Mean±SD p
Children with cerebral edema Children without cerebral edema 
Age (years) 9.65±3.63 9.00±3.87 0.610
Venous pH 6.99±0.12 7.05±0.15 0.182
Bicarbonate (mmol/L) 4.592±1.69 6±2.95 0.135
pCO2 (mmHg) 14.95±5.24 16.66±5.42 0.293
Blood glucose( mg/dl) 516.67±110.74 (408–790) 445.26±71.10 (289–580) 0.013 (95% CI-16.055–126.766)
BUN (mg/dl) 22.708±15.55 18.974±13.50 0.423
Calculated osmolality (mOsm/kg) 301.65±17.06 300.59±9.37 0.840
Serum Na (mmol/L) 132.42±7.53 134.5±4.31 0.216
Serum potassium (mmol/L) 4.708±0.15 4.659±0.12 0.837
BUN: Blood urea nitrogen, SD: Standard deviation, DKA: Diabetic ketoacidosis, CI: Confidence interval
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implicated. The factors intrinsic to DKA with probable worsening 
during treatment may be the cause of brain injury [27]. The 
degree of edema correlates with the degree of dehydration and 
hyperventilation at presentation [28]. Greater volumes of fluid 
given in the first 4 h [7,29] are also a risk factor for cerebral edema. 
In our study, an increased rate of cerebral edema was found in 
patients who received intravenous fluids boluses before starting 
treatment (p=0.02) which supports the literature evidence. Newly 
detected cases are more prone to develop cerebral edema [4,16]. 
A similar result is obtained in our study also (p=0.037).
All the 3 patients who received sodium bicarbonate injection 
during treatment developed cerebral edema (p=0.016) in our study. 
It is well described in literature that bicarbonate treatment is a risk 
factor for cerebral edema [2,4]. Controlled trials have shown no 
clinical benefit from bicarbonate administration [30]. Bicarbonate 
therapy may cause paradoxical CNS acidosis [4], and rapid 
correction of acidosis with bicarbonate causes hypokalemia [4,31]. 
Only indication for bicarbonate in DKA treatment is life-
threatening hyperkalemia [4,32].
An attenuated rise in serum sodium concentration or an early fall 
in glucose-corrected sodium during therapy [2,29] is a risk factor for 
cerebral edema. Serum sodium should rise by 0.5 mmol/L for each 
1mmol/L decrease in glucose concentration [4]. Steady increase 
in measured sodium which is ideally expected was not observed 
in our patient population even in patients without cerebral edema. 
But patients in the cerebral edema group showed more fluctuation 
of sodium level during treatment (Fig. 4).
Greater hypocapnia at presentation after adjusting for degree 
of acidosis [2,28] and more severe acidosis at presentation [7,29] 
is a risk for cerebral edema. The mean values of pH, bicarbonate 
and pCO2 were low in patients with cerebral edema in our series, 
even though statistical significance could not be observed. This 
may be due to the small sample size and absence of matching 
between patients with and without cerebral edema. Even though 
available data from other studies support the administration of 
insulin in the 1st hour of fluid treatment as a risk factor for cerebral 
edema [7] supporting evidence was not obtained in our study.
During treatment 35.3% patients developed hypokalemia 
in our study highlighting the importance of early potassium 
supplementation [4,31]. In fact, in our population in spite of 
potassium supplementation, this much of patients developed 
hypokalemia. In a study from North India, 14.5% had evidence 
of hypokalemia [33]. Hypokalemia is an important cause for 
mortality in DKA, and hence, potassium supplementation and 
monitoring should be emphasized.
The mean value for blood sugar was significantly higher in our 
study among the cases with cerebral edema. It is not described as 
a risk factor in other studies but is mentioned as a superimposing 
factor on the ischemic insult to brain which is implicated in the 
pathogenesis of cerebral edema [2,33,34].
This study has an inherent weakness of a retrospective study, 
so there could be measurement bias and issues of quality control 
of diagnostic tests. Also matching of study subjects could not be 
done. This study highlights the need for multicentric case–control 
studies from developing countries like India.
CONCLUSION
Infections are an important precipitating factor for DKA. 
Significant proportion of children developed cerebral edema 
during treatment. New cases, excess intravenous fluid boluses, 
high mean blood sugar at admission and bicarbonate administration 
were identified as risk factors for cerebral edema in DKA.
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